Press Articles

MetaCardis featured on France Inter

Karine Clément spoke to Mathieu Vidard on La Tête au Carré (Monday and Friday, 14h-15h) on France Inter on 11th September 2013. In this interview she discussed gut microbes, obesity, heart disease and the intriguing link between the lot.

logo France Inter Here is the summary (translated and edited)

“The intestinal flora (or microbiota) is composed of a population of one hundred thousand billion bacteria [Ed’s note: assumed to mean 100,000,000,000,000]. It watches over our physical health, improves nutrition and metabolism, and also plays a role in cognitive and mental functions. “If there is a disruption [to the microbiota], it can contribute to the development of diseases as diverse as diabetes and obesity, allergies, cognitive impairment and even the development of cancer. “When there is a deficiency of intestinal bacteria (in terms of a loss of diversity), this may contribute to the risk of developing obesity. “Obesity affected 400 million adults in 2005. By 2015, this number is expected to grow to more than 700 million people – and continue growing after that. “However, more and more evidence suggests that variations in our other genome, the microbiome (that is to say the overall genome of all the microorganisms in [and on] our body), might have a greater impact on the development of obesity than variations in the human genome.”

“The intestinal flora (or microbiota) is composed of a population of one hundred thousand billion bacteria [Ed’s note: assumed to mean 100,000,000,000,000]. It watches over our physical health, improves nutrition and metabolism, and also plays a role in cognitive and mental functions.

“If there is a disruption [to the microbiota], it can contribute to the development of diseases as diverse as diabetes and obesity, allergies, cognitive impairment and even the development of cancer.

“When there is a deficiency of intestinal bacteria (in terms of a loss of diversity), this may contribute to the risk of developing obesity.

“Obesity affected 400 million adults in 2005. By 2015, this number is expected to grow to more than 700 million people – and continue growing after that.

“However, more and more evidence suggests that variations in our other genome, the microbiome (that is to say the overall genome of all the microorganisms in [and on] our body), might have a greater impact on the development of obesity than variations in the human genome.”

“With Karine Clément, a physician specialising in nutrition and professor of nutrition at the Université Pierre et Marie Curie, Paris. She is also director of the new institute called ICAN, The Institute of Cardiometablism and Nutrition. Also joined (by telephone) by Gilles Mithieux, biologist and director of INSERM Unit 855 “Nutrition and Brain”. He explains the biological mechanisms responsible for the “appetite suppressant” effects of dietary protein. These results, published July 5th 2012 in Cell, envisage better management strategies of obese and overweight patients.”

“With Karine Clément, a physician specialising in nutrition and professor of nutrition at the Université Pierre et Marie Curie, Paris. She is also director of the new institute called ICAN, The Institute of Cardiometablism and Nutrition.

Also joined (by telephone) by Gilles Mithieux, biologist and director of INSERM Unit 855 “Nutrition and Brain”. He explains the biological mechanisms responsible for the “appetite suppressant” effects of dietary protein. These results, published July 5th 2012 in Cell, envisage better management strategies of obese and overweight patients.”

You can listen again here. Find out more here: http://www.franceinter.fr/emission-la-tete-au-carre-la-flore-intestinale-et-les-pathologies-liees

Share Post On:

Key facts

Full Title: Metagenomics in Cardiometabolic Diseases

Scientific Coordinator: Karine Clément, INSERM

Budget: EU contribution €11,999,992 ; Total costs: €20,387,421 (balance provided by partners)

Partners: 14 partners in six countries

Timing: Project length is 60 months and commenced 01/11/2012

Clinicaltrials.gov registration here

Horizonhealth.eu here

EC Cordis record and reports here

Related News

Project’s progress update

Project’s progress update Annual update on MetaCardis progress October 2017 Over the first 4 years, researchers involved in WP1 usedRead More

MetaCardis project five-year update: Analysis of data from 2000

MetaCardis project five-year update: Analysis of data from 2000 recruited subjects will yield insights about gut microbiota and cardiometabolic diseasesRead More

Joint press release from ICAN and Chalmers “Your gut

Joint press release from ICAN and Chalmers “Your gut bacteria determines which diet is best for weight reduction” Details Published:Read More

Press Release INSERM: The small intestine is involved in

Press Release INSERM: The small intestine is involved in chronic inflammation in obese people Obesity is caused by many complexRead More

Press Release: METACARDIS: a European project that deciphers the

Press Release: METACARDIS: a European project that deciphers the genes of the gut microbiota responsible for cardiometabolic diseases Details Published:Read More

Press Releases

The European Association for the Study of Obesity (EASO)

Press Articles The European Association for the Study of Obesity (EASO) published an interview on MetaCardis The coordinator of MetaCardis,Read More

Free read of “Gut microbiota and obesity: Concepts relevant

Press Articles Free read of “Gut microbiota and obesity: Concepts relevant to clinical care” until 5th of April The finalRead More

How can we find out what people are eating?

Press Articles How can we find out what people are eating? Assessing diet in the MetaCardis study Small changes inRead More

Interview with Prof. Karine Clément “Comment la microbiote influence

Press Articles Interview with Prof. Karine Clément “Comment la microbiote influence notre santé” CNRS radio Click here to listen toRead More